Covered recipient · General Payments record
MICHELLE M FUHRMANN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2022–2024
$999.41
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $682.36 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alkermes, Inc. | $263.06 | 7 |
| Janssen Pharmaceuticals, Inc | $250.00 | 2 |
| Indivior Inc. | $87.01 | 4 |
| Neos Therapeutics, LP | $24.91 | 1 |
| ABBVIE INC. | $21.26 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.95 | 1 |
| Orexo US, Inc. | $16.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.26 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107136764 | CMS |
| Alkermes, Inc. | $29.75 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120501512 | CMS |
| Alkermes, Inc. | $119.51 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120501514 | CMS |
| Alkermes, Inc. | $25.92 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120501516 | CMS |
| Alkermes, Inc. | $20.70 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120501518 | CMS |
| Alkermes, Inc. | $25.48 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120501520 | CMS |
| Alkermes, Inc. | $19.27 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120501522 | CMS |
| Alkermes, Inc. | $22.43 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120501524 | CMS |
| Indivior Inc. | $15.51 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144552762 | CMS |
| Indivior Inc. | $20.85 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144552764 | CMS |
| Indivior Inc. | $23.54 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144552766 | CMS |
| Indivior Inc. | $27.11 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144552768 | CMS |
| Janssen Pharmaceuticals, Inc | $150.00 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077948818 | CMS |
| Janssen Pharmaceuticals, Inc | $100.00 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077948820 | CMS |
| Neos Therapeutics, LP | $24.91 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082669375 | CMS |
| Orexo US, Inc. | $16.17 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136177370 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.95 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119075204 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.